ASH and ISTH sought to develop clinical practice guidelines on anticoagulant prophylaxis for pediatric patients who are at risk of VTE.

The study primary endpoint was met, showing non-inferiority vs. standard antimicrobial regimen in fungal free survival at Day 90 –– Study ...

Recommendations for anticoagulant prophylaxis for pediatric patients at risk for venous thromboembolism (VTE) have been presented.

The EMA has recommended expanding Privigen’s use to include measles pre- and postexposure prophylaxis in susceptible adults and children who cannot receive vaccination.

The phase 3, international, open-label, single-group XTEND-Kids study concluded that children with severe hemophilia A younger than 12 years benefited from treatment with efanesoctocog alfa ...

Previous reports suggest a benefit of fluconazole prophylaxis in extremely low birth weight (ELBW) infants <1000 g. Our aim was to evaluate if limiting fluconazole prophylaxis to targeted highest risk ...

Pharmacy students in the U.S. show limited knowledge of HIV prophylaxis, especially PEP, due to inadequate assessment tools. Pharmacists are pivotal in HIV prevention, but their knowledge of PrEP and ...

Cancer patients face a high risk for infection when undergoing cytotoxic chemotherapy and hematopoietic stem cell transplant (HSCT), particularly during the period of neutropenia. In this high-risk ...

Effective strategies are urgently needed to reduce mother-to-child transmission of human immunodeficiency virus type 1 (HIV-1) through breast-feeding in resource-limited settings. Women with HIV-1 ...

The study primary endpoint was met, showing non-inferiority vs. standard antimicrobial regimen in fungal free survival at Day ...

Mundipharma today announced positive Phase III topline results from the global ReSPECT clinical trial evaluating REZZAYO® (rezafungin acetate) for prophylaxis of invasive fungal diseases (IFDs) in ...